Signal Detection Trials
Signal Detection Trials - Related Videos
02:42
RNA CISH Signal Detection: A Technique to Detect Chromogenic Signals During RNA In Situ Hybridization in Intact Tissue Specimens
0 Views •
2023
This video presents the protocol for signal detection during RNA chromogenic in situ hybridization. This technique can be used to diagnose an active oncogenic infection visually in an intact tissue specimen.
01:28
The Trial Balance
0 Views •
2025
A trial balance is a fundamental financial statement that provides a snapshot of a company's accounts and their balances at a specific point in time. It serves as an essential tool for verifying the accuracy of financial records by ensuring that the total debits equal the total credits. Typically prepared at the end of an accounting period, a trial balance lists all ledger accounts in the order they appear, with debit balances in the left column and credit balances in the right column. The two...
01:16
Clinical Trials
0 Views •
2023
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias. There are four phases in a clinical trial. A phase one...
12:52
Detection of Signaling Effector-Complexes Downstream of BMP4 Using in situ PLA, a Proximity Ligation Assay
0 Views •
Cited by 34 •
2011
Here we show how to use Proximity Ligation Assay (PLA), with a combination of antibodies to visualize Bone Morphogenetic Protein (BMP) signaling in fixed cells. This technique allowed us to follow the nuclear accumulation of endogenous BMP activated effector-complexes and quantify their levels over time under BMP4 stimulation.
09:00
Detection of Protein Ubiquitination
0 Views •
Cited by 96 •
2009
Ubiquitination is a key posttranslational modification carried out by a set of three enzymes. Mutations of genes involved in this modification are associated with many different human diseases. Here, we describe protocols to detect protein ubiquitination in cultured cells in vivo and test tubes in vitro.
FAQs
The four response categories reveal different ways performance can succeed or fail. A hit occurs when a present target is reported, whereas a miss occurs when it is not detected. A false alarm reflects reporting a target that is absent, and a correct rejection reflects correctly withholding that response. Together, these outcomes provide the trial-level basis for evaluating detection performance.
Sensitivity and decision criterion describe different aspects of performance. Sensitivity concerns how well the nervous system or participant distinguishes a meaningful target from background noise. The criterion concerns the decision threshold used when classifying a stimulus as present or absent. Considering both measures helps determine whether an observed change reflects altered sensory processing, a shifted response tendency, or both.
Target-absent trials show whether participants can withhold a detection response when no meaningful signal is present. They provide the basis for identifying false alarms and correct rejections, which cannot be measured from target-present trials alone. Including both trial types therefore helps separate genuine signal detection from a general tendency to report that a target occurred.
Signal Detection Trials can test how attention, neurological conditions, or other experimental manipulations affect behaviorally relevant stimulus detection. Comparing response patterns or performance measures across conditions can show whether a manipulation changes discrimination of the signal, the participant’s decisions, or the relationship between these processes. This makes the task useful for linking perceptual performance with decision-making.
A basic workflow presents a target on some trials and withholds it on others, then records whether the participant indicates that the target was present. Responses are assigned to hit, miss, false-alarm, or correct-rejection categories. Repeating this structure across trials allows researchers to quantify performance with sensitivity and decision-criterion measures rather than relying on accuracy alone.
The framework applies to visual, auditory, and somatosensory processing. Researchers can examine how accurately a participant or nervous system detects meaningful information in each of these sensory domains, while recording the same response categories. This broad applicability supports comparisons of perceptual detection across different forms of sensory input and their relevance to behavior.
In neuroscience, these trials connect measurable responses with both perception and decision-making. A study might use them to examine whether attention changes detection of a relevant stimulus or whether a neurological condition is associated with altered performance. Sensitivity and decision-criterion measures help interpret those effects more precisely than a single overall accuracy score.